The therapeutic effect of some other SIRT-2 inhibitors relies on the combination of the cytotoxicity of the compounds and their inhibitory activity, having been observed that the compound toxicity was crucial in obtaining anti-cancer effects; this is the mechanism suggested for AC-93253 in prostate, pancreatic and lung cancer [94]. Here, SIRT2 is linked to cancer.